Nectar Lifesciences share news, announcements and annual reports
NSE: NECLIFEBSE: 532649Pharmaceuticals & BiotechnologySmall Cap
Nectar Lifesciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2005
Last close ₹10.18down ₹0.02 (0.20%)BSE ₹10.17
Share price at the NSE close on 2 Nov 2026. Previous close ₹10.20.
2 Nov: open ₹10.40, high ₹10.70, low ₹10.06
52-week range of traded prices to 2 Nov 2026
₹9.30Low, 30 Mar 2026₹22.40High, 23 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 2 Nov 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹198 Cr2,221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −31.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹171 crore of one-off items, the largest of them in the quarter to Sep 2025.
- −9.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 98,61771.1% delivered
Nectar Lifesciences board meetings
117 filed, newest first. Page 3 of 3.
Jan 2010
4 Jan · Board meeting
To consider and approve inter-alia amongst other items: (1) The Unaudited Financial (Provisional) Results of the Company for the quarter ended December 31, 2009; (2) The issue of GDRs/ ADRs/ equity shares or warrants/ securities convertible into equity shares/ any other domestic/ international offering, preferential issue/ QIP issue and to decide the matters incidental or ancillary thereto.
Oct 2009
15 Oct · Board meeting
Due to some unavoidable circumstances, the Board Meeting scheduled to be held on October 19, 2009 stands postponed to October 20, 2009 to consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the Company for the quarter ended on September 30, 2009.9 Oct · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the Company for the quarter ended on September 30, 2009.
Jul 2009
17 Jul · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on June 30, 2009.
Jun 2009
22 Jun · Board meeting
To consider and approve inter-alia amongst items: (1) The Audited Financial Results for Financial Year 2008-09, Balance Sheet of the company as at March 31, 2009 and Profit & Loss Accounts for the financial year ended on March 31, 2009 and matters related thereto. (2) The date of Annual General Meeting of Members of the Company for the Financial Year 2008-09 and matters related thereto. (3) Recommendation of final dividend to the Members of the company for Financial year 2008-09 and fix the Book closure dates and matters related thereto.
Jan 2009
20 Jan · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on December 31, 2008.
Oct 2008
20 Oct · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on September 30, 2008.
Aug 2008
21 Aug · Board meeting
To consider, inter-alia, the issue of GDR's / ADR's / equity shares or warrants / securities convertible into equity shares / any other domestic / international offering and to decide the matters incidental or ancillary thereto.
Jul 2008
18 Jul · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on June 30, 2008.
Jun 2008
11 Jun · Board meeting
To consider and approve inter-alia amongst other items:(1) The Audited Financial Results for Financial Year 2007-08, Balance Sheet of the company as at 31.03.2008 and Profit & Loss Accounts for the financial year ended on 31.03.2008 and matters related thereto.(2) The date of Annual General Meeting of Members of the Company for the Financial Year 2007-08 and matters related thereto.(3) Recommendation of final dividend to the Members of the company for Financial Year 2007-08 and fix the Book closure dates and matters related thereto.
Apr 2008
21 Apr · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on March 31, 2008.
Jan 2008
17 Jan · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on December 31, 2007.
Oct 2007
18 Oct · Board meeting
To consider and approve, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on September 30, 2007.
Aug 2007
27 Aug · Board meeting
To consider and approve inter-alia amongst other items: (1) The Balance Sheet of the Company as at March 31, 2007 and Profit & Loss Accounts for the Financial year ended on March 31, 2007 and matters related thereto. (2) The Date of Annual General Meeting of Members of the Company for the Financial year 2006-07 and matters related thereto. (3) Recommendation of Final Dividend to the Members of the Company for Financial year 2006-07 and fix the book Closure dates and matters related thereto.
Jul 2007
18 Jul · Board meeting
Meeting on 30 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Apr 2007
21 Apr · Board meeting
Meeting on 28 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”
Jan 2007
15 Jan · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on December 31,2006.